Your browser doesn't support javascript.
loading
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease.
Socinski, Mark A; Kaye, Frederic J; Spigel, David R; Kudrik, Fred J; Ponce, Santiago; Ellis, Peter M; Majem, Margarita; Lorigan, Paul; Gandhi, Leena; Gutierrez, Martin E; Nepert, Dale; Corral, Jesus; Ares, Luis Paz.
Afiliación
  • Socinski MA; Division of Hematology/Oncology, Univeristy of Pittsburgh Cancer Institute, Pittsburgh, PA. Electronic address: socinskima@upmc.edu.
  • Kaye FJ; Hematology-Oncology, University of Florida College of Medicine, Gainesville, FL.
  • Spigel DR; Lung Cancer Research Program, Sarah Cannon Research Institute, Nashville, TN.
  • Kudrik FJ; Cancer Center, South Carolina Oncology Associates, Columbia, SC.
  • Ponce S; Medical Oncology Department, Hospital Universitario 12 de Octubre and Lung Cancer Unit CNIO, Madrid, Spain.
  • Ellis PM; Medical Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
  • Majem M; Servei d'Oncologia Mèdica, Hospital Sant Pau, Barcelona, Spain.
  • Lorigan P; Division of Molecular and Clinical Cancer Sciences, University of Manchester/Christie NHS Foundation Trust, Manchester, UK.
  • Gandhi L; Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA.
  • Gutierrez ME; Bienes Cancer Center, Holy Cross Hospital, Fort Lauderdale, FL.
  • Nepert D; Clinical Development, ImmunoGen Inc, Waltham, MA.
  • Corral J; Medical Oncology Department, Hospital Universitario 12 de Octubre and Lung Cancer Unit CNIO, Madrid, Spain.
  • Ares LP; Medical Oncology Department, Hospital Universitario 12 de Octubre and Lung Cancer Unit CNIO, Madrid, Spain.
Clin Lung Cancer ; 18(1): 68-76.e2, 2017 01.
Article en En | MEDLINE | ID: mdl-28341109
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Inmunoconjugados / Antígeno CD56 / Carcinoma Pulmonar de Células Pequeñas / Terapia Molecular Dirigida / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Inmunoconjugados / Antígeno CD56 / Carcinoma Pulmonar de Células Pequeñas / Terapia Molecular Dirigida / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article